FDA approves new blood test to screen for colon cancer that should be covered by insurance: 'It's going to have a huge impact'

The FDA has approved Shield, a blood test from California-based Guardant Health, which is designed to detect colorectal cancer. The test is expected to be covered by most insurance plans following approval.